Agenda
1:00-1:10 p.m. Welcome Remarks – Andrew Murr, MD
Moderator - Jolie Chang, MD
1:10-1:30 p.m. Separating Signal from Noise in Auditory Cortex
Brian Malone, PhD
1:30-1:50 p.m. Precision Head and Neck Cancer Strategies
Jennifer Grandis, MD
1:50-2:10 p.m. Assessment of Musical Sound Quality in Cochlear Implant Users
Charles Limb, MD
2:10-2:30 p.m. Cellular Therapy for Organ/Tissue Repair: Parathyroid and Tracheal
Dieter Gruenert, PhD
2:30-3:00 p.m. INTERMISSION - light refreshments
3:00-3:20 p.m. Research in Rhinology
Andrew Goldberg, MD
3:20-3:40 p.m. The Molecular Biology of Adenoid Cystic Carcinoma
Patrick Ha, MD
3:40-4:00 p.m. Research Projects in FPRS
Rahul Seth, MD
ADJOURN
Disclosure: Drs. Grandis, Gruenert, Ha, Malone, Seth, and moderator Jolie Chang, MD and planning committee members Mark Courey, MD; Steven Pletcher, MD; have stated they have no relationships to disclose.
Dr. Andrew H. Murr, MD, FACS is a stockholder for Intersect ENT Pharmaceuticals. Dr. Andrew N. Goldberg, MD, MSCE is a consultant for Siesta Medical Inc., Apnicure and holder of intellectual property rights for UCSF. Dr. Charles J. Limb, MD has relations with Genentech through his spouse's employment; grant and research support for Advanced Bionics Corporations and Med El Corporation
Accreditation: The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council to provide continuing medical education for physicians.
Designation: UCSF designates this live activity for a maximum of 70 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
UCSF Department of Otolaryngology - Head and Neck Surgery (Course #MGR16041)